This might further induce bias because of prescription preferences between classes due to relevant adverse event risk factors
Mild injection site redness and swelling that resolves within days is common and usually not serious
Severe GI adverse reactions have also been reported postmarketing with GLP-1 receptor agonists
Individual Presentation Your results are analyzed to understand your degree of insulin resistance, metabolic profile, and current symptoms
Figure from van der Aart-van der Beek AB, Nat Rev Nephrol, 2020 The Study Methods This was an international, event-driven, double-blind, parallel-group, randomized, placebo-controlled trial conducted at 387 sites in 28 countries comparing semaglutide to placebo in patients with T2DM and CKD, both being treated with baseline standard of care
Semaglutide works through one receptor system